Stacey S. Degarmo

FDA investigator

Appears on 10 documents from 2010 to 2016, mostly at sites in Massachusetts. Most often cites design and construction features (21 CFR 211.42).

10
Documents on file
7.5
Observations per 483
2010
First seen
2016
Most recent

What they cite most

From 45 observations

Activity by year

2010: 2, 2012: 1, 2013: 1, 2014: 2, 2015: 1, 2016: 3

Where

Massachusetts 6 · New Hampshire 4

Is Stacey S. Degarmo coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Cambridge Isotope Laboratories, Inc.Mar 25, 2016 · Andover, Massachusetts
Response Anderson Holdings, Inc. dba Wingate's Pharmacy and CompoundingMar 3, 2016 · Stoneham, Massachusetts
483 Anderson Holdings Inc.Feb 19, 2016 · Nashua, New Hampshire
483 Bedford Pharmacy Inc.Aug 28, 2015 · Bedford, New Hampshire
Response Northern New England Compounding Pharmacy, LLC dba Eastern States Compounding PharmacyOct 8, 2014 · Littleton, New Hampshire
483 Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma ServicesJan 29, 2014 · Bedford, New Hampshire
483 Central Admixture Pharmacy Services, Inc. (CAPS)Jan 7, 2013 · Woburn, Massachusetts

About this profile

What does Stacey S. Degarmo inspect?

Stacey S. Degarmo appears on 10 documents on file covering 9 sites, mostly in Massachusetts.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Stacey S. Degarmo is dated Mar 25, 2016.